Interleukin-6 (IL-6) -572C→G promoter polymorphism is associated with type 2 diabetes risk in Koreans

Clinical Endocrinology

Volumn 70, Issue 2, 2009, Pages 238-244

  Koh, Soo Jeong ^a   Jang, Yangsoo ^b   Hyun, Yae Jung ^a   Park, Ju Yeon ^a   Song, Young Duk ^c   Shin, Kyung Kyun ^a,d   Chae, Jey Sook ^a   Kim, Byung Keuk ^b   Ordovas, Jose M ^e   Lee, Jong Ho ^a  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c National Health Insurance Corporation   (South Korea)

^d CHA University   (South Korea)

^e TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; GLUCOSE TOLERANCE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENOTYPE; HOMOZYGOTE; HUMANS; INSULIN; INTERLEUKIN-6; KOREA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 58549086336     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03315.x     Document Type: Article

References (27)

1. Hu, F.B., Meigs, J.B., Li, T.Y. et al. (2004) Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes, 53, 693 700.
2. Pradhan, A.D., Manson, J.E., Rifai, N. et al. (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Journal of the American Medical Association, 286, 327 334.
3. Herder, C., Peltonen, M., Koenig, W. et al. (2006) Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: results from the Finnish Diabetes Prevention Study. Diabetes, 55, 2340 2346.
4. Spranger, J., Kroke, A., Möhlig, M. et al. (2003) Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC) - Potsdam Study. Diabetes, 52, 812 817.
5. Nishimoto, N. Kishimoto, T. (2006) Interleukin 6: from bench to bedside. Nature Clinical Practice. Rheumatology, 2, 619 626. Erratum in 2, 691.
6. Hamid, Y.H., Rose, C.S., Urhammer, S.A. et al. (2005) Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes. Diabetologia, 48, 251 260.
7. Kitamura, A., Hasegawa, G., Obayashi, H. et al. (2002) Interleukin-6 polymorphism (-634C/G) in the promoter region and the progression of diabetic nephropathy in type 2 diabetes. Diabetic Medicine, 19, 1000 1005.
8. Fu, H.X., Zhang, J.Y., Li, G.S. et al. (2006) Study on linkage between polymorphism of interleukin 6 gene -572C/G and susceptibility to myocardial infarction. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 23, 245 249.
9. Cardellini, M., Perego, L., D'Adamo, M. et al. (2005) C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance. Diabetes Care, 28, 2007 2012.
10. Brull, D.J., Montgomery, H.E., Sanders, J. et al. (2001) Interleukin-6 gene -174G > C and -572G > C promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arteriosclerosis, Thrombosis, and Vascular Biology, 21, 1458 1463.
11. Jones, K.G., Brull, D.J., Brown, L.C. et al. (2001) Interleukin-6 (IL-6) and the prognosis ofabdominal aortic aneurysms. Circulation, 103, 2260 2265.
12. Huth, C., Heid, I.M., Vollmert, C. et al. (2006) IL-6 gene promoter polymorphisms and type 2 diabetes: joint analysis of individual participants' data from 21 studies. Diabetes, 55, 2915 2921.
13. Georges, J.L., Loukaci, V., Poirier, O. et al. (2001) Interleukin-6 gene polymorphisms and susceptibility to myocardial infarcion: the ECTIM study. Journal of Molecular Medicine, 79, 300 305.
14. Humphries, S.E., Luong, L.A., Ogg, M.S. et al. (2001) The interleukin-6 -174G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. European Heart Journal, 22, 2243 2252.
15. Lim, C.S., Zheng, S., Kim, Y.S. et al. (2002) The -174 G to C polymorphism of interleukin-6 gene is very rare in Koreans. Cytokine, 19, 52 54.
16. Nakajima, T., Ota, N., Yoshida, H. et al. (1999) Allelic variants in the interleukin-6 gene and essential hypertension in Japanese women. Genes and Immunity, 1, 115 119.
17. Park, B.L., Lee, H.S., Kim, Y.J. et al. (2003) Association between interleukin 6 promoter variants and chronic hepatitis B progression. Experimental and Molecular Medicine, 35, 76 82.
18. Basso, F., Lowe, G.D., Rumley, A. et al. (2002) Interleukin-6 -174G > C polymorphism and risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS). Arteriosclerosis, Thrombosis, and Vascular Biology, 22, 599 604.
19. Yamada, Y., Ando, F., Niino, N. et al. (2003) Association of polymorphisms of interleukin-6, osteocalcin, and vitamin D receptor genes, alone or in combination, with bone mineral density in community-dwelling Japanese women and men. Journal of Clinical Endocrinology and Metabolism, 88, 3372 3378.
20. Wong, L.Y., Leung, R.Y., Ong, K.L. et al. (2007) Plasma levels of fibrinogen and C-reactive protein are related to interleukin-6 gene -572C > G polymorphism in subjects with and without hypertension. Journal of Human Hypertension, 21, 875 882.
21. Saijo, Y., Yoshioka, E., Fukui, T. et al. (2007) Effects of the interaction between interleukin-6 -634C/G polymorphism and smoking on serum C-reactive protein concentrations. Hypertension Research, 30, 593 599.
22. Freeman, D.J., Norrie, J., Caslake, M.J. et al. (2002) West of Scotland Coronary Prevention Study. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes, 51, 1596 1600.
23. Castoldi, G., Galimberti, S., Riva, C. et al. (2007) Association between serum values of C-reactive protein and cytokine production in whole blood of patients with type 2 diabetes. Clinical Science, 113, 103 108.
24. Barbara, T., Hannelore, L., Andrea, S. et al. (2003) C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men. Archives of Internal Medicine, 163, 93 99.
25. Paik, J.K., Kim, O.Y., Koh, S.J. et al. (2007) Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors. Clinica Chimica Acta, 380, 68 74.
26. Fu, H.X., Li, G.S., Li, Y. et al. (2006) Interleukin-6 -597G/A and -572C/G polymorphisms and risk of coronary heart disease. Zhonghua Xin Xue Guan Bing Za Zhi, 34, 519 522.
27. Bennermo, M., Held, C., Green, F. et al. (2004) Prognostic value of plasma interleukin-6 concentrations and the -174 G > C and -572 G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis. Atherosclerosis, 174, 157 163.